BRAVEHEART BIO INC
BRVENASDAQ๐ #2053 by market capUS Equity
$20.42โฒ $1.16 (+6.05%)
Market closed ยท at closeTrack BRVE
Get earnings, price moves & breaking news on Telegram
24hโฒ 6.0%
7dโ
14dโ
30dโ
ytdโ
1yโ
๐ฆMarket Cap
$1.44B
Small Cap
๐Revenue Growth (YoY)
0.0%
Slowing
๐Gross Margin
0.0%
Thin
๐ตFCF Margin
0.0%
Thin
โ๏ธP/S Ratio
0.0x
Cheap
Otter Score
โ
Insufficient data
No chart data available for BRVE.
Trading Snapshot
- Day Range
- $19.47 โ $21.00
- 52-Week Range
- $16.70 โ $32.00
- Volume (shares)
- 38,865
- Avg Volume (shares)
- โ
- Shares Outstanding
- 70.7M
- Next Earnings
- โ
Fundamentals Snapshot
- Annual Revenue
- โ
- Last Q Revenue
- โ
- P/E Ratio
- -6.0
- P/S Ratio
- 0.0x
- EPS (TTM)
- $-1.19
- Dividend Yield
- 0.00%
BRAVEHEART BIO INC
BRVEFinancial Trends
Financial history unavailable.
About BRAVEHEART BIO INC
Braveheart Bio, Inc. engages in the development of therapeutics to treat hypertrophic cardiomyopathy. Its lead product candidate is BHB-1839 which is a small-molecule cardiac myosin inhibitor. The company was founded on May 13,2024 and is headquartered in San Francisco, CA.
๐ฆฆ
Otter Score Breakdown
How it's scoredFive components, each rated 1โ5โ and equally weighted (20%), averaged to a 0โ100 score:๐ Quality โ gross margin๐ Growth โ revenue YoYโ๏ธ Valuation โ P/S ratioโก Momentum โ 30-day price change๐ง Dilution โ 1-yr share issuance (buybacks score higher)Insufficient data for all five components.
๐Qualityโ
โ
โ
โ
โ
๐Growthโ
โ
โ
โ
โ
โ๏ธValuationโ
โ
โ
โ
โ
โกMomentumโ
โ
โ
โ
โ
Overall Score
Insufficient data
โ/100
Analyst data unavailable.
Latest News & Updates
News unavailable.